{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:45:51Z","timestamp":1791747951352,"version":"4.3.4"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330094"],"award-info":[{"award-number":["82330094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFF1501304"],"award-info":[{"award-number":["2024YFF1501304"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Leading Talent Program Project","award":["LJ2024013"],"award-info":[{"award-number":["LJ2024013"]}]},{"name":"the Natural Science Foundation of Shanghai","award":["23ZR1441300"],"award-info":[{"award-number":["23ZR1441300"]}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["23QC1401400"],"award-info":[{"award-number":["23QC1401400"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Oriental Talent Plan Youth Program","award":["QNJY2025090"],"award-info":[{"award-number":["QNJY2025090"]}]},{"name":"\"Cross-Fund Project\" of Xinhua Hospital","award":["JC2025G008"],"award-info":[{"award-number":["JC2025G008"]}],"id":[{"id":"https:\/\/ror.org\/04dzvks42","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10495-026-02425-9","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:09:00Z","timestamp":1791050940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring regulated cell death in renal cell carcinoma: mechanistic insights and therapeutic perspectives"],"prefix":"10.1007","volume":"31","author":[{"given":"Guanyu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangbiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghao","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingnan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbo","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5268-0886","authenticated-orcid":false,"given":"Xiuwu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"issue":"2","key":"2425_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM (2024) Cell death. Cell 187(2):235\u2013256. https:\/\/doi.org\/10.1016\/j.cell.2023.11.044. (PubMed PMID: 38242081)","journal-title":"Cell"},{"issue":"5","key":"2425_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D (2024) A guide to cell death pathways. Nat Rev Mol Cell Biol 25(5):379\u2013395. https:\/\/doi.org\/10.1038\/s41580-023-00689-6. (PubMed PMID: 38110635)","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2425_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molcel.2023.11.040","volume":"84","author":"Y Ai","year":"2024","unstructured":"Ai Y, Meng Y, Yan B, Zhou Q, Wang X (2024) The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death. Mol Cell 84(1):170\u2013179. https:\/\/doi.org\/10.1016\/j.molcel.2023.11.040. (PubMed PMID: 38181758)","journal-title":"Mol Cell"},{"issue":"3","key":"2425_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4PubMedPMID:29362479;PubMedCentralPMCID:PMC5864239","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P et al (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25(3):486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4PubMedPMID:29362479;PubMedCentralPMCID:PMC5864239","journal-title":"Cell Death Differ"},{"issue":"6","key":"2425_CR5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex A, Ghanem YA, Albiges L, Bonn S, Campi R, Capitanio U et al (2025) European Association of Urology Guidelines on Renal Cell Carcinoma: the 2025 update. Eur Urol 87(6):683\u2013696. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.020","journal-title":"Eur Urol"},{"issue":"1","key":"2425_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer Statistics, 2021. CA Cancer J Clin 71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654. (PubMed PMID: 33433946)","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"2425_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","volume":"16","author":"WM Linehan","year":"2019","unstructured":"Linehan WM, Ricketts CJ (2019) The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol 16(9):539\u2013552. https:\/\/doi.org\/10.1038\/s41585-019-0211-5. (PubMed PMID: 31278395)","journal-title":"Nat Rev Urol"},{"issue":"5","key":"2425_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, Comp\u00e9rat EM, Gill AJ, Hartmann A et al (2022) The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol 82(5):458\u2013468. https:\/\/doi.org\/10.1016\/j.eururo.2022.06.016. (PubMed PMID: 35853783)","journal-title":"Eur Urol"},{"issue":"34","key":"2425_CR9","doi-asserted-by":"publisher","first-page":"14391","DOI":"10.1073\/pnas.0907357106PubMedPMID:19706526;PubMedCentralPMCID:PMC2726037","volume":"106","author":"JA Bertout","year":"2009","unstructured":"Bertout JA, Majmundar AJ, Gordan JD, Lam JC, Ditsworth D, Keith B et al (2009) HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc Natl Acad Sci U S A 106(34):14391\u201314396. https:\/\/doi.org\/10.1073\/pnas.0907357106PubMedPMID:19706526;PubMedCentralPMCID:PMC2726037","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"2425_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010PubMedPMID:24439385;PubMedCentralPMCID:PMC4076414","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1\u20132):317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010PubMedPMID:24439385;PubMedCentralPMCID:PMC4076414","journal-title":"Cell"},{"issue":"7826","key":"2425_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8PubMedPMID:32939090;PubMedCentralPMCID:PMC8051864","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P et al (2020) Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature 585(7826):603\u2013608. https:\/\/doi.org\/10.1038\/s41586-020-2732-8PubMedPMID:32939090;PubMedCentralPMCID:PMC8051864","journal-title":"Nature"},{"issue":"40","key":"2425_CR12","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/s41388-018-0315-zPubMedPMID:29872221;PubMedCentralPMCID:PMC6173300","volume":"37","author":"H Miess","year":"2018","unstructured":"Miess H, Dankworth B, Gouw AM, Rosenfeldt M, Schmitz W, Jiang M et al (2018) The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene 37(40):5435\u20135450. https:\/\/doi.org\/10.1038\/s41388-018-0315-zPubMedPMID:29872221;PubMedCentralPMCID:PMC6173300","journal-title":"Oncogene"},{"issue":"6586","key":"2425_CR13","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529PubMedPMID:35298263;PubMedCentralPMCID:PMC9273333","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M et al (2022) Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375(6586):1254\u20131261. https:\/\/doi.org\/10.1126\/science.abf0529PubMedPMID:35298263;PubMedCentralPMCID:PMC9273333","journal-title":"Science"},{"issue":"3","key":"2425_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2PubMedPMID:36747082;PubMedCentralPMCID:PMC10027392","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M et al (2023) Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol 25(3):404\u2013414. https:\/\/doi.org\/10.1038\/s41556-023-01091-2PubMedPMID:36747082;PubMedCentralPMCID:PMC10027392","journal-title":"Nat Cell Biol"},{"issue":"8","key":"2425_CR15","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/s41589-025-01841-3","volume":"21","author":"W Fu","year":"2025","unstructured":"Fu W, Wang J, Li T, Qiao Y, Zhang Z, Zhang X et al (2025) Persistent activation of TRPM4 triggers necrotic cell death characterized by sodium overload. Nat Chem Biol 21(8):1238\u20131249. https:\/\/doi.org\/10.1038\/s41589-025-01841-3. (PubMed PMID: 39915626)","journal-title":"Nat Chem Biol"},{"key":"2425_CR16","doi-asserted-by":"publisher","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088 PubMed PMID: 23550210; PubMed Central PMCID: PMC4160307.","DOI":"10.1126\/scisignal.2004088"},{"issue":"11","key":"2425_CR17","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.3390\/ijms23116198PubMedPMID:35682876;PubMedCentralPMCID:PMC9181490","volume":"23","author":"C Ganini","year":"2022","unstructured":"Ganini C, Montanaro M, Scimeca M, Palmieri G, Anemona L, Concetti L et al (2022) No Time to Die: How Kidney Cancer Evades Cell Death. Int J Mol Sci 23(11):6198. https:\/\/doi.org\/10.3390\/ijms23116198PubMedPMID:35682876;PubMedCentralPMCID:PMC9181490","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2425_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075PubMedPMID:29617669;PubMedCentralPMCID:PMC6075733","volume":"23","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E et al (2018) The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23(1):313-326.e5. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.075PubMedPMID:29617669;PubMedCentralPMCID:PMC6075733","journal-title":"Cell Rep"},{"issue":"2","key":"2425_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","volume":"80","author":"T Miyashita","year":"1995","unstructured":"Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80(2):293\u2013299. https:\/\/doi.org\/10.1016\/0092-8674(95)90412-3. (PubMed PMID: 7834749)","journal-title":"Cell"},{"issue":"1","key":"2425_CR20","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/s41467-021-22655-6PubMedPMID:33863900;PubMedCentralPMCID:PMC8052441","volume":"12","author":"H Wei","year":"2021","unstructured":"Wei H, Qu L, Dai S, Li Y, Wang H, Feng Y et al (2021) Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis. Nat Commun 12(1):2280. https:\/\/doi.org\/10.1038\/s41467-021-22655-6PubMedPMID:33863900;PubMedCentralPMCID:PMC8052441","journal-title":"Nat Commun"},{"issue":"12","key":"2425_CR21","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.7150\/jca.85650PubMedPMID:37576393;PubMedCentralPMCID:PMC10414049","volume":"14","author":"S Kim","year":"2023","unstructured":"Kim S, Kim DE, Kang H, Hong VS, Jeon J, Lee J et al (2023) KMU-191 Induces Apoptosis in Human Clear Cell Renal Cell Carcinoma Caki Cells Through Modulation of Bcl-xL, Mcl-1 (L), c-FLIP (L), and p53 Proteins. J Cancer 14(12):2224\u20132235. https:\/\/doi.org\/10.7150\/jca.85650PubMedPMID:37576393;PubMedCentralPMCID:PMC10414049","journal-title":"J Cancer"},{"issue":"2","key":"2425_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0022-5347(05)68635-1","volume":"162","author":"A Huang","year":"1999","unstructured":"Huang A, Fone PD, Gandour-Edwards R, White RW, Low RK (1999) Immunohistochemical analysis of BCL-2 protein expression in renal cell carcinoma. J Urol 162(2):610\u2013613 (PubMed PMID: 10411096)","journal-title":"J Urol"},{"issue":"3","key":"2425_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1097-0215(19960503)66:3<322::AID-IJC9>3.0.CO;2-0","volume":"66","author":"Y Tomita","year":"1996","unstructured":"Tomita Y, Bilim V, Kawasaki T, Takahashi K, Okan I, Magnusson KP et al (1996) Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53. Int J Cancer 66(3):322\u2013325. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19960503)66:3%3c322::AID-IJC9%3e3.0.CO;2-0. (PubMed PMID: 8621251)","journal-title":"Int J Cancer"},{"key":"2425_CR24","doi-asserted-by":"publisher","first-page":"1614378","DOI":"10.3389\/fonc.2025.1614378PubMedPMID:40837014;PubMedCentralPMCID:PMC12361231","volume":"15","author":"L Huang","year":"2025","unstructured":"Huang L, Wang L, Yuan D, Xu Y, Wang Y, Yao K et al (2025) Overexpression of BNIP3 in renal carcinoma cells can promote apoptosis of renal carcinoma cells through HIF-1\u03b1-BNIP3-mediated autophagy. Front Oncol 15:1614378. https:\/\/doi.org\/10.3389\/fonc.2025.1614378PubMedPMID:40837014;PubMedCentralPMCID:PMC12361231","journal-title":"Front Oncol"},{"issue":"10","key":"2425_CR25","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41417-025-00953-1","volume":"32","author":"N Mahmoud","year":"2025","unstructured":"Mahmoud N, Qin X, Bzeih W, Khabibullin D, Alchoueiry M, Safi S et al (2025) BCL-xL dependency in chromophobe renal cell carcinoma. Cancer Gene Ther 32(10):1133\u20131143. https:\/\/doi.org\/10.1038\/s41417-025-00953-1. (PubMed PMID: 40819113)","journal-title":"Cancer Gene Ther"},{"key":"2425_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101150","volume":"77","author":"X Zeng","year":"2024","unstructured":"Zeng X, Chen Z, Zhu Y, Liu L, Zhang Z, Xiao Y et al (2024) O-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother 77:101150. https:\/\/doi.org\/10.1016\/j.drup.2024.101150. (PubMed PMID: 39276723)","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"issue":"10","key":"2425_CR27","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.chembiol.2023.06.026PubMedPMID:37527661;PubMedCentralPMCID:PMC10592443","volume":"30","author":"EF Ahanin","year":"2023","unstructured":"Ahanin EF, Sager RA, Backe SJ, Dunn DM, Dushukyan N, Blanden AR et al (2023) Catalytic inhibitor of Protein Phosphatase 5 activates the extrinsic apoptotic pathway by disrupting complex II in kidney cancer. Cell Chem Biol 30(10):1223-1234.e12. https:\/\/doi.org\/10.1016\/j.chembiol.2023.06.026PubMedPMID:37527661;PubMedCentralPMCID:PMC10592443","journal-title":"Cell Chem Biol"},{"issue":"1","key":"2425_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.15430\/JCP.24.032PubMedPMID:40201024;PubMedCentralPMCID:PMC11973461","volume":"30","author":"G Park","year":"2025","unstructured":"Park G, Baniya MK, Cha EJ, Sim SJ, Choi JS, Chun KS (2025) Domperidone Induces Apoptosis through Suppression of STAT3 Signaling in Human Renal Cancer Caki-2 Cells. J Cancer Prev 30(1):24\u201331. https:\/\/doi.org\/10.15430\/JCP.24.032PubMedPMID:40201024;PubMedCentralPMCID:PMC11973461","journal-title":"J Cancer Prev"},{"issue":"7","key":"2425_CR29","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/s41418-023-01176-3PubMedPMID:37173391;PubMedCentralPMCID:PMC10307860","volume":"30","author":"S Wang","year":"2023","unstructured":"Wang S, Wang T, Zhang X, Cheng S, Chen C, Yang G et al (2023) The deubiquitylating enzyme USP35 restricts regulated cell death to promote survival of renal clear cell carcinoma. Cell Death Differ 30(7):1757\u20131770. https:\/\/doi.org\/10.1038\/s41418-023-01176-3PubMedPMID:37173391;PubMedCentralPMCID:PMC10307860","journal-title":"Cell Death Differ"},{"issue":"5","key":"2425_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3892\/ol.2022.13521PubMedPMID:36276495;PubMedCentralPMCID:PMC9533662","volume":"24","author":"JH Jang","year":"2022","unstructured":"Jang JH, Lee TJ, Sung EG, Song IH, Kim JY (2022) Dapagliflozin induces apoptosis by downregulating cFILPL and increasing cFILPS instability in Caki-1 cells. Oncol Lett 24(5):401. https:\/\/doi.org\/10.3892\/ol.2022.13521PubMedPMID:36276495;PubMedCentralPMCID:PMC9533662","journal-title":"Oncol Lett"},{"key":"2425_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116877","volume":"236","author":"JH Jang","year":"2025","unstructured":"Jang JH, Kim H, Jun H, Park CY, Kim JY, Yeo M et al (2025) Targeting RBM39 with Tasisulam enhances TRAIL-induced apoptosis through DR5 upregulation and Bcl-2 downregulation in renal cell carcinoma. Biochem Pharmacol 236:116877. https:\/\/doi.org\/10.1016\/j.bcp.2025.116877. (PubMed PMID: 40112928)","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2425_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12935-022-02726-4PubMedPMID:36182900;PubMedCentralPMCID:PMC9526279","volume":"22","author":"HTM Ong","year":"2022","unstructured":"Ong HTM, Kim TH, Ates E, Pyun JC, Kang MJ (2022) Overexpression of CYP11A1 recovers cell cycle distribution in renal cell carcinoma Caki-1. Cancer Cell Int 22(1):299. https:\/\/doi.org\/10.1186\/s12935-022-02726-4PubMedPMID:36182900;PubMedCentralPMCID:PMC9526279","journal-title":"Cancer Cell Int"},{"issue":"2","key":"2425_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.7150\/ijms.69060PubMedPMID:35165523;PubMedCentralPMCID:PMC8795799","volume":"19","author":"W Chen","year":"2022","unstructured":"Chen W, Lin W, Wu L, Xu A, Liu C, Huang P (2022) A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature. Int J Med Sci 19(2):377\u2013392. https:\/\/doi.org\/10.7150\/ijms.69060PubMedPMID:35165523;PubMedCentralPMCID:PMC8795799","journal-title":"Int J Med Sci"},{"key":"2425_CR34","doi-asserted-by":"publisher","unstructured":"M C, Q Y, J H, H W, Z L, Z F, et al. Identification and Validation of a Necroptosis-Related Prognostic Signature for Kidney Renal Clear Cell Carcinoma. Stem Cells Int. 2023 Mar 3;2023. https:\/\/doi.org\/10.1155\/2023\/8446765 PubMed PMID: 36910333.","DOI":"10.1155\/2023\/8446765"},{"issue":"5","key":"2425_CR35","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/cancers14051114PubMedPMID:35267423;PubMedCentralPMCID:PMC8909272","volume":"14","author":"SD Markowitsch","year":"2022","unstructured":"Markowitsch SD, Vakhrusheva O, Schupp P, Akele Y, Kitanovic J, Slade KS et al (2022) Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT\/mTOR Signaling Pathway. Cancers 14(5):1114. https:\/\/doi.org\/10.3390\/cancers14051114PubMedPMID:35267423;PubMedCentralPMCID:PMC8909272","journal-title":"Cancers"},{"key":"2425_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09536-4","author":"K Kelepouras","year":"2025","unstructured":"Kelepouras K, Saggau J, Bonasera D, Kiefer C, Locci F, Rakhsh-Khorshid H et al (2025) STING induces ZBP1-mediated necroptosis independently of TNFR1 and FADD. Nature. https:\/\/doi.org\/10.1038\/s41586-025-09536-4. (PubMed PMID: 40834903)","journal-title":"Nature"},{"issue":"11","key":"2425_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113377","volume":"42","author":"T Yang","year":"2023","unstructured":"Yang T, Wang G, Zhang M, Hu X, Li Q, Yun F et al (2023) Triggering endogenous Z-RNA sensing for anti-tumor therapy through ZBP1-dependent necroptosis. Cell Rep 42(11):113377. https:\/\/doi.org\/10.1016\/j.celrep.2023.113377. (PubMed PMID: 37922310)","journal-title":"Cell Rep"},{"issue":"7610","key":"2425_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding J, Wang K, Liu W, She Y, Sun Q, Shi J et al (2016) Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535(7610):111\u2013116. https:\/\/doi.org\/10.1038\/nature18590. (PubMed PMID: 27281216)","journal-title":"Nature"},{"issue":"7610","key":"2425_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629PubMedPMID:27383986;PubMedCentralPMCID:PMC5539988","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H et al (2016) Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535(7610):153\u2013158. https:\/\/doi.org\/10.1038\/nature18629PubMedPMID:27383986;PubMedCentralPMCID:PMC5539988","journal-title":"Nature"},{"key":"2425_CR40","doi-asserted-by":"publisher","unstructured":"X Z, X W, Y W, S W, C J, L Y, et al. Pyroptosis Regulators and Tumor Microenvironment Infiltration Characterization in Clear Cell Renal Cell Carcinoma. Front Oncol. 2022 May 1;11. https:\/\/doi.org\/10.3389\/fonc.2021.774279 PubMed PMID: 35070978.","DOI":"10.3389\/fonc.2021.774279"},{"key":"2425_CR41","doi-asserted-by":"publisher","unstructured":"X T, A Z, Y F, Y S, X W, F J, et al. A Novel Pyroptosis-Related lncRNAs Signature for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma and Its Associations with Immunity. J Oncol. 2021 Oct 18;2021. https:\/\/doi.org\/10.1155\/2021\/9997185 PubMed PMID: 34764994.","DOI":"10.1155\/2021\/9997185"},{"key":"2425_CR42","doi-asserted-by":"publisher","unstructured":"J Z, Y W, J M, A A. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function. Front Oncol. 2023 Jun 7;13. https:\/\/doi.org\/10.3389\/fonc.2023.1163714 PubMed PMID: 37483501.","DOI":"10.3389\/fonc.2023.1163714"},{"key":"2425_CR43","doi-asserted-by":"publisher","unstructured":"X T, Z L, Y L. Identification of gasdermin B function in the progression of renal clear cell carcinoma by a pan-cancer analysis. Discov Oncol. 2024 Nov 26;15(1). https:\/\/doi.org\/10.1007\/s12672-024-01613-w PubMed PMID: 39589674.","DOI":"10.1007\/s12672-024-01613-w"},{"issue":"Pt 2","key":"2425_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.143129","volume":"310","author":"X Zhang","year":"2025","unstructured":"Zhang X, Li J, He J, Li Y, Sun D, Zhang W (2025) Glutathion peroxidase 4 (GPX4) and Ribosomal Protein L40 (RPL40) participate in arsenic induced progression of renal cell carcinoma by regulating the NLRP3 mediated classic pyroptosis pathway. Int J Biol Macromol 310(Pt 2):143129. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143129. (PubMed PMID: 40239794)","journal-title":"Int J Biol Macromol"},{"issue":"266","key":"2425_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115542","volume":"1","author":"Y Li","year":"2023","unstructured":"Li Y, Zhong G, He T, Quan J, Liu S, Liu Z et al (2023) Effect of arsenic and copper in kidney of mice: Crosstalk between Nrf2\/ Keap1 pathway in apoptosis and pyroptosis. Ecotoxicol Environ Saf 1(266):115542. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.115542. (PubMed PMID: 37801897)","journal-title":"Ecotoxicol Environ Saf"},{"key":"2425_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115794","volume":"216","author":"BA Abdel-Wahab","year":"2023","unstructured":"Abdel-Wahab BA, El-Shoura EAM, Shafiuddin Habeeb M, Zafaar D (2023) Febuxostat alleviates Arsenic Trioxide-Induced renal injury in Rats: Insights on the crosstalk between NLRP3\/TLR4, Sirt-1\/NF-\u03baB\/TGF-\u03b2 signaling Pathways, and miR-23b-3p, miR-181a-5b expression. Biochem Pharmacol 216:115794. https:\/\/doi.org\/10.1016\/j.bcp.2023.115794. (PubMed PMID: 37689273)","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2425_CR47","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.7150\/ijbs.79853PubMedPMID:36923928;PubMedCentralPMCID:PMC10008700","volume":"19","author":"Q Wang","year":"2023","unstructured":"Wang Q, Gao S, Shou Y, Jia Y, Wei Z, Liu Y et al (2023) AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis. Int J Biol Sci 19(4):1266\u20131283. https:\/\/doi.org\/10.7150\/ijbs.79853PubMedPMID:36923928;PubMedCentralPMCID:PMC10008700","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2425_CR48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41419-020-2431-2PubMedPMID:32303673;PubMedCentralPMCID:PMC7165180","volume":"11","author":"YF Tan","year":"2020","unstructured":"Tan YF, Wang M, Chen ZY, Wang L, Liu XH (2020) Inhibition of BRD4 prevents proliferation and epithelial-mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis. Cell Death Dis 11(4):239. https:\/\/doi.org\/10.1038\/s41419-020-2431-2PubMedPMID:32303673;PubMedCentralPMCID:PMC7165180","journal-title":"Cell Death Dis"},{"issue":"Pt 2","key":"2425_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113498","volume":"143","author":"R Xi","year":"2024","unstructured":"Xi R, Cao Y, Fu N, Sheng Y, Yu J, Li L et al (2024) Allosteric inhibition of the tyrosine phosphatase SHP2 enhances the anti-tumor immunity of interferon \u03b1 through induction of caspase-1-mediated pyroptosis in renal cancer. Int Immunopharmacol 143(Pt 2):113498. https:\/\/doi.org\/10.1016\/j.intimp.2024.113498. (PubMed PMID: 39467353)","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"2425_CR50","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/1878-0261.13770PubMedPMID:39592433;PubMedCentralPMCID:PMC11977649","volume":"19","author":"M Johnson","year":"2025","unstructured":"Johnson M, Turcotte S (2025) Loss of SETD2 in wild-type VHL clear cell renal cell carcinoma sensitizes cells to STF-62247 and leads to DNA damage, cell cycle arrest, and cell death characteristic of pyroptosis. Mol Oncol 19(4):1244\u20131264. https:\/\/doi.org\/10.1002\/1878-0261.13770PubMedPMID:39592433;PubMedCentralPMCID:PMC11977649","journal-title":"Mol Oncol"},{"issue":"9","key":"2425_CR51","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2174\/156802608784535075","volume":"8","author":"BJ Goodwin","year":"2008","unstructured":"Goodwin BJ, Zuercher WJ, Collins JL (2008) Recent advances in liver X receptor biology and chemistry. Curr Top Med Chem 8(9):781\u2013791. https:\/\/doi.org\/10.2174\/156802608784535075. (PubMed PMID: 18537688)","journal-title":"Curr Top Med Chem"},{"issue":"16","key":"2425_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202500141","volume":"14","author":"Y Du","year":"2025","unstructured":"Du Y, Mai Y, Liu Z, Lin G, Luo S, Guo C et al (2025) Synergistic Provoking of Pyroptosis and STING Pathway by Multifunctional Manganese-Polydopamine Nano-Immunomodulator for Enhanced Renal Cell Carcinoma Immunotherapy. Adv Healthc Mater 14(16):e2500141. https:\/\/doi.org\/10.1002\/adhm.202500141. (PubMed PMID: 40394938)","journal-title":"Adv Healthc Mater"},{"issue":"11\u201312","key":"2425_CR53","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s10495-022-01766-5","volume":"27","author":"L Liu","year":"2022","unstructured":"Liu L, Jin H, Dong M, Tian J, Li H, Liu Q et al (2022) Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma. Apoptosis Int J Program Cell Death 27(11\u201312):946\u2013960. https:\/\/doi.org\/10.1007\/s10495-022-01766-5. (PubMed PMID: 36028785)","journal-title":"Apoptosis Int J Program Cell Death"},{"key":"2425_CR54","doi-asserted-by":"publisher","first-page":"1473203","DOI":"10.3389\/fimmu.2024.1473203PubMedPMID:39399506;PubMedCentralPMCID:PMC11466770","volume":"15","author":"C He","year":"2024","unstructured":"He C, Li Q, Wu W, Liu K, Li X, Zheng H et al (2024) Ferroptosis-associated genes and compounds in renal cell carcinoma. Front Immunol 15:1473203. https:\/\/doi.org\/10.3389\/fimmu.2024.1473203PubMedPMID:39399506;PubMedCentralPMCID:PMC11466770","journal-title":"Front Immunol"},{"key":"2425_CR55","doi-asserted-by":"publisher","unstructured":"Green YS, Ferreira Dos Santos MC, Fuja DG, Reichert EC, Campos AR, Cowman SJ, et al. ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma. Oncogene. 2022 Oct;41(42):4709\u201323. https:\/\/doi.org\/10.1038\/s41388-022-02460-1 PubMed PMID: 36097192; PubMed Central PMCID: PMC9568429.","DOI":"10.1038\/s41388-022-02460-1"},{"key":"2425_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.929838PubMedPMID:36059676;PubMedCentralPMCID:PMC9428356","volume":"12","author":"T Zhu","year":"2022","unstructured":"Zhu T, Xiao Z, Yuan H, Tian H, Chen T, Chen Q et al (2022) ACO1 and IREB2 downregulation confer poor prognosis and correlate with autophagy-related ferroptosis and immune infiltration in KIRC. Front Oncol 12:929838. https:\/\/doi.org\/10.3389\/fonc.2022.929838PubMedPMID:36059676;PubMedCentralPMCID:PMC9428356","journal-title":"Front Oncol"},{"issue":"8","key":"2425_CR57","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41419-023-06057-8PubMedPMID:37604811;PubMedCentralPMCID:PMC10442429","volume":"14","author":"W Xue","year":"2023","unstructured":"Xue W, Jian W, Meng Y, Wang T, Cai L, Yu Y et al (2023) Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC. Cell Death Dis 14(8):539. https:\/\/doi.org\/10.1038\/s41419-023-06057-8PubMedPMID:37604811;PubMedCentralPMCID:PMC10442429","journal-title":"Cell Death Dis"},{"issue":"23","key":"2425_CR58","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1158\/0008-5472.CAN-23-0969PubMedPMID:37729394;PubMedCentralPMCID:PMC10690093","volume":"83","author":"L Zhou","year":"2023","unstructured":"Zhou L, Luo Y, Liu Y, Zeng Y, Tong J, Li M et al (2023) Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression. Cancer Res 83(23):3920\u20133939. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0969PubMedPMID:37729394;PubMedCentralPMCID:PMC10690093","journal-title":"Cancer Res"},{"issue":"13","key":"2425_CR59","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1158\/0008-5472.CAN-23-2926PubMedPMID:38640229;PubMedCentralPMCID:PMC11290988","volume":"84","author":"D Wang","year":"2024","unstructured":"Wang D, Mahmud I, Thakur VS, Tan SK, Isom DG, Lombard DB et al (2024) GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma. Cancer Res 84(13):2141\u20132154. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2926PubMedPMID:38640229;PubMedCentralPMCID:PMC11290988","journal-title":"Cancer Res"},{"key":"2425_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.977960PubMedPMID:36407113;PubMedCentralPMCID:PMC9669761","volume":"10","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Liu Z, Li B, Gong Z, Piao C, Du Y et al (2022) Integrated analysis of transcriptomics, proteomics and metabolomics data reveals the role of SLC39A1 in renal cell carcinoma. Front Cell Dev Biol 10:977960. https:\/\/doi.org\/10.3389\/fcell.2022.977960PubMedPMID:36407113;PubMedCentralPMCID:PMC9669761","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"2425_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113023PubMedPMID:37691145;PubMedCentralPMCID:PMC10591818","volume":"42","author":"VV Phadnis","year":"2023","unstructured":"Phadnis VV, Snider J, Varadharajan V, Ramachandiran I, Deik AA, Lai ZW et al (2023) MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis. Cell Rep 42(9):113023. https:\/\/doi.org\/10.1016\/j.celrep.2023.113023PubMedPMID:37691145;PubMedCentralPMCID:PMC10591818","journal-title":"Cell Rep"},{"issue":"1","key":"2425_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40170-022-00290-zPubMedPMID:36192773;PubMedCentralPMCID:PMC9528056","volume":"10","author":"TD Klasson","year":"2022","unstructured":"Klasson TD, LaGory EL, Zhao H, Huynh SK, Papandreou I, Moon EJ et al (2022) ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma. Cancer Metab 10(1):14. https:\/\/doi.org\/10.1186\/s40170-022-00290-zPubMedPMID:36192773;PubMedCentralPMCID:PMC9528056","journal-title":"Cancer Metab"},{"key":"2425_CR63","doi-asserted-by":"publisher","unstructured":"L M, Pj K, M T, Jy C, Gc F, A T, et al. Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State. Cell Chem Biol. 2019 Mar 21;26(3). https:\/\/doi.org\/10.1016\/j.chembiol.2018.11.016 PubMed PMID: 30686757.","DOI":"10.1016\/j.chembiol.2018.11.016"},{"issue":"4","key":"2425_CR64","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41419-023-05779-zPubMedPMID:37024452;PubMedCentralPMCID:PMC10079857","volume":"14","author":"J Hao","year":"2023","unstructured":"Hao J, Chen Q, Feng Y, Jiang Q, Sun H, Deng B et al (2023) Combination treatment with FAAH inhibitors\/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway. Cell Death Dis 14(4):247. https:\/\/doi.org\/10.1038\/s41419-023-05779-zPubMedPMID:37024452;PubMedCentralPMCID:PMC10079857","journal-title":"Cell Death Dis"},{"issue":"632","key":"2425_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217942","volume":"1","author":"T Xu","year":"2025","unstructured":"Xu T, Liu H, Ling N, Chen D, Dai J, Chen W et al (2025) OTUD3-mediated stabilization of SLC7A11 drives sunitinib resistance by suppressing ferroptosis in clear cell renal cell carcinoma. Cancer Lett 1(632):217942. https:\/\/doi.org\/10.1016\/j.canlet.2025.217942. (PubMed PMID: 40716486)","journal-title":"Cancer Lett"},{"issue":"7\u20138","key":"2425_CR66","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s10495-024-01953-6","volume":"29","author":"Z Li","year":"2024","unstructured":"Li Z, Tian Y, Zong H, Wang X, Li D, Keranmu A et al (2024) Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells. Apoptosis Int J Program Cell Death 29(7\u20138):1051\u20131069. https:\/\/doi.org\/10.1007\/s10495-024-01953-6. (PubMed PMID: 38553613)","journal-title":"Apoptosis Int J Program Cell Death"},{"issue":"3","key":"2425_CR67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-023-05719-xPubMedPMID:36906674;PubMedCentralPMCID:PMC10008556","volume":"14","author":"L Kang","year":"2023","unstructured":"Kang L, Wang D, Shen T, Liu X, Dai B, Zhou D et al (2023) PDIA4 confers resistance to ferroptosis via induction of ATF4\/SLC7A11 in renal cell carcinoma. Cell Death Dis 14(3):193. https:\/\/doi.org\/10.1038\/s41419-023-05719-xPubMedPMID:36906674;PubMedCentralPMCID:PMC10008556","journal-title":"Cell Death Dis"},{"issue":"7755","key":"2425_CR68","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-yPubMedPMID:31043744;PubMedCentralPMCID:PMC6533917","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK et al (2019) CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569(7755):270\u2013274. https:\/\/doi.org\/10.1038\/s41586-019-1170-yPubMedPMID:31043744;PubMedCentralPMCID:PMC6533917","journal-title":"Nature"},{"issue":"1","key":"2425_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-024-02122-8PubMedPMID:39748364;PubMedCentralPMCID:PMC11694429","volume":"24","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang T, Li Q, Zheng Z, Liao L, Cen J et al (2025) circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4. Mol Cancer 24(1):1. https:\/\/doi.org\/10.1186\/s12943-024-02122-8PubMedPMID:39748364;PubMedCentralPMCID:PMC11694429","journal-title":"Mol Cancer"},{"issue":"1","key":"2425_CR70","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41419-025-07848-xPubMedPMID:40651948;PubMedCentralPMCID:PMC12255702","volume":"16","author":"H Yang","year":"2025","unstructured":"Yang H, Zhang Z, Feng N, Zhao K, Zhang Y, Yin X et al (2025) CENPT prevents renal cell carcinoma against ferroptosis by enhancing the synthesis of glutathione. Cell Death Dis 16(1):517. https:\/\/doi.org\/10.1038\/s41419-025-07848-xPubMedPMID:40651948;PubMedCentralPMCID:PMC12255702","journal-title":"Cell Death Dis"},{"key":"2425_CR71","doi-asserted-by":"publisher","unstructured":"Y P, S L, G S, M C, L F, C C, et al. STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis. Cell Death Dis. 2025 Feb 23;16(1). https:\/\/doi.org\/10.1038\/s41419-025-07456-9 PubMed PMID: 39988631.","DOI":"10.1038\/s41419-025-07456-9"},{"issue":"148","key":"2425_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114098","volume":"20","author":"Z Yan","year":"2025","unstructured":"Yan Z, Li Y, Wang M, Xu K, Liu Y, Wang L et al (2025) O-GlcNAcylation of DJ-1 suppresses ferroptosis in renal cell carcinoma by affecting the transsulfuration pathway. Int Immunopharmacol 20(148):114098. https:\/\/doi.org\/10.1016\/j.intimp.2025.114098. (PubMed PMID: 39842141)","journal-title":"Int Immunopharmacol"},{"key":"2425_CR73","doi-asserted-by":"publisher","unstructured":"W N, Y L, L L, S Y, M Z, C L, et al. Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade Ferroptosis. J Biomed Nanotechnol. 2022 Jan 2;18(2). https:\/\/doi.org\/10.1166\/jbn.2022.3250 PubMed PMID: 35484753.","DOI":"10.1166\/jbn.2022.3250"},{"key":"2425_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.994741PubMedPMID:36186457;PubMedCentralPMCID:PMC9523472","volume":"13","author":"X Huang","year":"2022","unstructured":"Huang X, Wang T, Ye J, Feng H, Zhang X, Ma X et al (2022) FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis. Front Genet 13:994741. https:\/\/doi.org\/10.3389\/fgene.2022.994741PubMedPMID:36186457;PubMedCentralPMCID:PMC9523472","journal-title":"Front Genet"},{"issue":"8","key":"2425_CR75","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.62347\/ETJH6697PubMedPMID:36119838;PubMedCentralPMCID:PMC9442008","volume":"12","author":"X Qi","year":"2022","unstructured":"Qi X, Wang J, Che X, Li Q, Li X, Wang Q et al (2022) The potential value of cuprotosis (copper-induced cell death) in the therapy of clear cell renal cell carcinoma. Am J Cancer Res 12(8):3947\u20133966. https:\/\/doi.org\/10.62347\/ETJH6697PubMedPMID:36119838;PubMedCentralPMCID:PMC9442008","journal-title":"Am J Cancer Res"},{"issue":"10","key":"2425_CR76","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/biology13100793PubMedPMID:39452102;PubMedCentralPMCID:PMC11505359","volume":"13","author":"E Ooko","year":"2024","unstructured":"Ooko E, Ali NT, Efferth T (2024) Identification of Cuproptosis-Associated Prognostic Gene Expression Signatures from 20 Tumor Types. Biology 13(10):793. https:\/\/doi.org\/10.3390\/biology13100793PubMedPMID:39452102;PubMedCentralPMCID:PMC11505359","journal-title":"Biology"},{"issue":"1","key":"2425_CR77","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s40001-023-01137-zPubMedPMID:37189176;PubMedCentralPMCID:PMC10184413","volume":"28","author":"G Luo","year":"2023","unstructured":"Luo G, Wang L, Zheng Z, Gao B, Lei C (2023) Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma. Eur J Med Res 28(1):176. https:\/\/doi.org\/10.1186\/s40001-023-01137-zPubMedPMID:37189176;PubMedCentralPMCID:PMC10184413","journal-title":"Eur J Med Res"},{"issue":"10","key":"2425_CR78","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3390\/genes13101725PubMedPMID:36292610;PubMedCentralPMCID:PMC9601362","volume":"13","author":"S Zeng","year":"2022","unstructured":"Zeng S, Zhang H, Zhang D, Hu X, Song L (2022) Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator FDX1 in Clear Cell Renal Cell Carcinoma. Genes 13(10):1725. https:\/\/doi.org\/10.3390\/genes13101725PubMedPMID:36292610;PubMedCentralPMCID:PMC9601362","journal-title":"Genes"},{"issue":"10","key":"2425_CR79","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300474R","volume":"37","author":"X Wang","year":"2023","unstructured":"Wang X, Jia JH, Zhang M, Meng QS, Yan BW, Ma ZY et al (2023) Adrenomedullin\/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis. FASEB J Off Publ Fed Am Soc Exp Biol 37(10):e23143. https:\/\/doi.org\/10.1096\/fj.202300474R. (PubMed PMID: 37698353)","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"1","key":"2425_CR80","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12935-025-03882-zPubMedPMID:40551107;PubMedCentralPMCID:PMC12186379","volume":"25","author":"W Xu","year":"2025","unstructured":"Xu W, Chen XC, Wang Y, Chen JC, Cao ZJ, Huang R et al (2025) Palmitoylation regulators drive the progression of clear cell renal cell carcinoma through Inhibition of cuproptosis: insights into the role of ZDHHC18. Cancer Cell Int 25(1):230. https:\/\/doi.org\/10.1186\/s12935-025-03882-zPubMedPMID:40551107;PubMedCentralPMCID:PMC12186379","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2425_CR81","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12672-024-01023-yPubMedPMID:38797784;PubMedCentralPMCID:PMC11128431","volume":"15","author":"R Feng","year":"2024","unstructured":"Feng R, Li H, Meng T, Fei M, Yang C (2024) Bioinformatics analysis and experimental validation of m6A and cuproptosis-related lncRNA NFE4 in clear cell renal cell carcinoma. Discov Oncol 15(1):187. https:\/\/doi.org\/10.1007\/s12672-024-01023-yPubMedPMID:38797784;PubMedCentralPMCID:PMC11128431","journal-title":"Discov Oncol"},{"issue":"1","key":"2425_CR82","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/cells12010173PubMedPMID:36611966;PubMedCentralPMCID:PMC9818076","volume":"12","author":"M Xie","year":"2022","unstructured":"Xie M, Cheng B, Yu S, He Y, Cao Y, Zhou T et al (2022) Cuproptosis-Related MiR-21-5p\/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment. Cells 12(1):173. https:\/\/doi.org\/10.3390\/cells12010173PubMedPMID:36611966;PubMedCentralPMCID:PMC9818076","journal-title":"Cells"},{"issue":"1","key":"2425_CR83","doi-asserted-by":"publisher","first-page":"27053","DOI":"10.1038\/s41598-024-78713-8PubMedPMID:39511359;PubMedCentralPMCID:PMC11543667","volume":"14","author":"Z Che","year":"2024","unstructured":"Che Z, Jin W, Wu Y, Li H, Liang P (2024) Rhomboid-like 2 correlated with TME infiltration inhibits cuproptosis-related genes and drives malignant phenotype in clear cell renal cell carcinoma. Sci Rep 14(1):27053. https:\/\/doi.org\/10.1038\/s41598-024-78713-8PubMedPMID:39511359;PubMedCentralPMCID:PMC11543667","journal-title":"Sci Rep"},{"key":"2425_CR84","doi-asserted-by":"publisher","unstructured":"Vujani\u0107 GM, Gessler M, Ooms AHAG, Collini P, Coulomb-l\u2019Hermine A, D\u2019Hooghe E, et al. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nat Rev Urol. 2018 Nov;15(11):693\u2013701. https:\/\/doi.org\/10.1038\/s41585-018-0100-3 PubMed PMID: 30310143; PubMed Central PMCID: PMC7136175.","DOI":"10.1038\/s41585-018-0100-3"},{"issue":"5","key":"2425_CR85","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","volume":"43","author":"Z Yang","year":"2025","unstructured":"Yang Z, Su W, Wei X, Pan Y, Xing M, Niu L et al (2025) Hypoxia inducible factor-1\u03b1 drives cancer resistance to cuproptosis. Cancer Cell 43(5):937-954.e9. https:\/\/doi.org\/10.1016\/j.ccell.2025.02.015. (PubMed PMID: 40054467)","journal-title":"Cancer Cell"},{"issue":"4","key":"2425_CR86","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41556-020-0496-xPubMedPMID:32231310;PubMedCentralPMCID:PMC7194135","volume":"22","author":"X Liu","year":"2020","unstructured":"Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X et al (2020) Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol 22(4):476\u2013486. https:\/\/doi.org\/10.1038\/s41556-020-0496-xPubMedPMID:32231310;PubMedCentralPMCID:PMC7194135","journal-title":"Nat Cell Biol"},{"issue":"5","key":"2425_CR87","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1074\/jbc.RA119.011471PubMedPMID:31914417;PubMedCentralPMCID:PMC6996897","volume":"295","author":"JH Joly","year":"2020","unstructured":"Joly JH, Delfarah A, Phung PS, Parrish S, Graham NA (2020) A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose. J Biol Chem 295(5):1350\u20131365. https:\/\/doi.org\/10.1074\/jbc.RA119.011471PubMedPMID:31914417;PubMedCentralPMCID:PMC6996897","journal-title":"J Biol Chem"},{"issue":"1","key":"2425_CR88","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41698-025-00834-8PubMedPMID:39994355;PubMedCentralPMCID:PMC11850913","volume":"9","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li Z, Lu H, Jiang Z, Song Y, Ye Z et al (2025) Pan-cancer analysis uncovered the prognostic and therapeutic value of disulfidptosis. NPJ Precis Oncol 9(1):50. https:\/\/doi.org\/10.1038\/s41698-025-00834-8PubMedPMID:39994355;PubMedCentralPMCID:PMC11850913","journal-title":"NPJ Precis Oncol"},{"key":"2425_CR89","doi-asserted-by":"publisher","first-page":"1288240","DOI":"10.3389\/fimmu.2024.1288240PubMedPMID:38292868;PubMedCentralPMCID:PMC10824999","volume":"15","author":"K Xu","year":"2024","unstructured":"Xu K, Li D, Qian J, Zhang Y, Zhang M, Zhou H et al (2024) Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy. Front Immunol 15:1288240. https:\/\/doi.org\/10.3389\/fimmu.2024.1288240PubMedPMID:38292868;PubMedCentralPMCID:PMC10824999","journal-title":"Front Immunol"},{"issue":"1","key":"2425_CR90","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12864-024-10307-0PubMedPMID:38671348;PubMedCentralPMCID:PMC11046872","volume":"25","author":"L Ren","year":"2024","unstructured":"Ren L, Liu J, Lin Q, He T, Huang G, Wang W et al (2024) Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients. BMC Genomics 25(1):413. https:\/\/doi.org\/10.1186\/s12864-024-10307-0PubMedPMID:38671348;PubMedCentralPMCID:PMC11046872","journal-title":"BMC Genomics"},{"issue":"1","key":"2425_CR91","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41598-024-51197-2PubMedPMID:38182642;PubMedCentralPMCID:PMC10770353","volume":"14","author":"N Wang","year":"2024","unstructured":"Wang N, Hu Y, Wang S, Xu Q, Jiao X, Wang Y et al (2024) Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma. Sci Rep 14(1):624. https:\/\/doi.org\/10.1038\/s41598-024-51197-2PubMedPMID:38182642;PubMedCentralPMCID:PMC10770353","journal-title":"Sci Rep"},{"key":"2425_CR92","doi-asserted-by":"publisher","first-page":"1343819","DOI":"10.3389\/fphar.2024.1343819PubMedPMID:38549669;PubMedCentralPMCID:PMC10976849","volume":"15","author":"Y Feng","year":"2024","unstructured":"Feng Y, Wang W, Jiang S, Liu Y, Wang Y, Zhan X et al (2024) Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma. Front Pharmacol 15:1343819. https:\/\/doi.org\/10.3389\/fphar.2024.1343819PubMedPMID:38549669;PubMedCentralPMCID:PMC10976849","journal-title":"Front Pharmacol"},{"key":"2425_CR93","doi-asserted-by":"publisher","unstructured":"Rupert C, Dell\u2019 Aversana C, Mosca L, Montanaro V, Arcaniolo D, De Sio M, et al. Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models. J Exp Clin Cancer Res CR. 2023 May 26;42(1):134. https:\/\/doi.org\/10.1186\/s13046-023-02713-1 PubMed PMID: 37231503; PubMed Central PMCID: PMC10214673.","DOI":"10.1186\/s13046-023-02713-1"},{"issue":"38","key":"2425_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404693PubMedPMID:39119834;PubMedCentralPMCID:PMC11481186","volume":"11","author":"Y Luo","year":"2024","unstructured":"Luo Y, Guan B, Deng X, Bai P, Huang H, Miao C et al (2024) Methuosis Inducer SGI-1027 Cooperates with Everolimus to Promote Apoptosis and Pyroptosis by Triggering Lysosomal Membrane Permeability in Renal Cancer. Adv Sci Weinh Baden-Wurtt Ger 11(38):e2404693. https:\/\/doi.org\/10.1002\/advs.202404693PubMedPMID:39119834;PubMedCentralPMCID:PMC11481186","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"issue":"22","key":"2425_CR95","doi-asserted-by":"publisher","first-page":"5710","DOI":"10.3390\/cancers14225710PubMedPMID:36428802;PubMedCentralPMCID:PMC9688814","volume":"14","author":"L Zhang","year":"2022","unstructured":"Zhang L, Jin GZ, Li D (2022) Tat-hspb1 Suppresses Clear Cell Renal Cell Carcinoma (ccRCC) Growth via Lysosomal Membrane Permeabilization. Cancers 14(22):5710. https:\/\/doi.org\/10.3390\/cancers14225710PubMedPMID:36428802;PubMedCentralPMCID:PMC9688814","journal-title":"Cancers"},{"issue":"1","key":"2425_CR96","doi-asserted-by":"publisher","first-page":"8067","DOI":"10.1038\/s41598-025-92674-6PubMedPMID:40055463;PubMedCentralPMCID:PMC11889168","volume":"15","author":"L Naldi","year":"2025","unstructured":"Naldi L, Catalano M, Melica ME, Polvani S, Papini D, Landini I et al (2025) Effects of reduced extracellular sodium on proliferation and invasive activity of renal cell carcinoma cell lines. Sci Rep 15(1):8067. https:\/\/doi.org\/10.1038\/s41598-025-92674-6PubMedPMID:40055463;PubMedCentralPMCID:PMC11889168","journal-title":"Sci Rep"},{"issue":"11","key":"2425_CR97","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41556-024-01503-x","volume":"26","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu J, Yuan W, Zhang Q, Luo X, Li Y et al (2024) Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8+ T cells. Nat Cell Biol 26(11):1892\u20131902. https:\/\/doi.org\/10.1038\/s41556-024-01503-x. (PubMed PMID: 39261719)","journal-title":"Nat Cell Biol"},{"issue":"6365","key":"2425_CR98","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1126\/science.aam9305PubMedPMID:29025995;PubMedCentralPMCID:PMC5748897","volume":"358","author":"JB Spinelli","year":"2017","unstructured":"Spinelli JB, Yoon H, Ringel AE, Jeanfavre S, Clish CB, Haigis MC (2017) Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science 358(6365):941\u2013946. https:\/\/doi.org\/10.1126\/science.aam9305PubMedPMID:29025995;PubMedCentralPMCID:PMC5748897","journal-title":"Science"},{"issue":"5","key":"2425_CR99","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s42255-022-00568-yPubMedPMID:35534729;PubMedCentralPMCID:PMC9177652","volume":"4","author":"C Cheng","year":"2022","unstructured":"Cheng C, Geng F, Li Z, Zhong Y, Wang H, Cheng X et al (2022) Ammonia stimulates SCAP\/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth. Nat Metab 4(5):575\u2013588. https:\/\/doi.org\/10.1038\/s42255-022-00568-yPubMedPMID:35534729;PubMedCentralPMCID:PMC9177652","journal-title":"Nat Metab"},{"key":"2425_CR100","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fcimb.2019.00406PubMedPMID:31850239;PubMedCentralPMCID:PMC6902032","volume":"9","author":"RKS Malireddi","year":"2019","unstructured":"Malireddi RKS, Kesavardhana S, Kanneganti TD (2019) ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome\/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis). Front Cell Infect Microbiol 9:406. https:\/\/doi.org\/10.3389\/fcimb.2019.00406PubMedPMID:31850239;PubMedCentralPMCID:PMC6902032","journal-title":"Front Cell Infect Microbiol"},{"key":"2425_CR101","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fcimb.2020.00238PubMedPMID:32582562;PubMedCentralPMCID:PMC7283380","volume":"10","author":"P Samir","year":"2020","unstructured":"Samir P, Malireddi RKS, Kanneganti TD (2020) The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis). Front Cell Infect Microbiol 10:238. https:\/\/doi.org\/10.3389\/fcimb.2020.00238PubMedPMID:32582562;PubMedCentralPMCID:PMC7283380","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"2425_CR102","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41419-023-06370-2PubMedPMID:38129399;PubMedCentralPMCID:PMC10739961","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, Zhu Y, Zhang L, Guo L, Wang X, Pan Z et al (2023) Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases. Cell Death Dis 14(12):851. https:\/\/doi.org\/10.1038\/s41419-023-06370-2PubMedPMID:38129399;PubMedCentralPMCID:PMC10739961","journal-title":"Cell Death Dis"},{"issue":"5\u20136","key":"2425_CR103","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10495-023-01932-3","volume":"29","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Wang J, Dao C, Zhu M, Li Y, Liu F et al (2024) Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma. Apoptosis 29(5\u20136):681\u2013692. https:\/\/doi.org\/10.1007\/s10495-023-01932-3. (PubMed PMID: 38281281)","journal-title":"Apoptosis"},{"issue":"1","key":"2425_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03630-9","volume":"25","author":"K Yang","year":"2025","unstructured":"Yang K, Wang Y, Jian Y, Wang B, Du H, Xia Y et al (2025) CASP5 associated with PANoptosis promotes tumorigenesis and progression of clear cell renal cell carcinoma. Cancer Cell Int 25(1):8. https:\/\/doi.org\/10.1186\/s12935-024-03630-9. (PubMed PMID: 39780201; PubMed Central PMCID: PMC11716502)","journal-title":"Cancer Cell Int"},{"issue":"39","key":"2425_CR105","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039874","volume":"103","author":"D Yue","year":"2024","unstructured":"Yue D, Ren C, Li H, Liu X (2024) Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma. Medicine (Baltimore) 103(39):e39874. https:\/\/doi.org\/10.1097\/MD.0000000000039874. (PubMed PMID: 39331898; PubMed Central PMCID: PMC11441883)","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"2425_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119392","volume":"24","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhou J, Zhang N, Zhu Y, Zhong Y, Wang Z et al (2023) A novel defined PANoptosis-related miRNA signature for predicting the prognosis and immune characteristics in clear cell renal cell carcinoma: a miRNA signature for the prognosis of ccRCC. Int J Mol Sci 24(11):9392. https:\/\/doi.org\/10.3390\/ijms24119392. (PubMed PMID: 37298343; PubMed Central PMCID: PMC10253790)","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2425_CR107","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V (2018) Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 18(2):134\u2013147. https:\/\/doi.org\/10.1038\/nri.2017.105. (PubMed PMID: 28990587)","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2425_CR108","doi-asserted-by":"publisher","first-page":"27156","DOI":"10.1038\/s41598-025-11095-7PubMedPMID:40715295;PubMedCentralPMCID:PMC12297447","volume":"15","author":"Z Yu","year":"2025","unstructured":"Yu Z, Xu Z, Zhang X, Shao W, Zhong D, Yan X et al (2025) NETosis-based prognostic model reveals immune modulation in clear cell renal cell carcinoma using single-cell and bulk RNA sequencing. Sci Rep 15(1):27156. https:\/\/doi.org\/10.1038\/s41598-025-11095-7PubMedPMID:40715295;PubMedCentralPMCID:PMC12297447","journal-title":"Sci Rep"},{"key":"2425_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.771545PubMedPMID:34993135;PubMedCentralPMCID:PMC8724023","volume":"11","author":"B Shang","year":"2021","unstructured":"Shang B, Guo L, Shen R, Cao C, Xie R, Jiang W et al (2021) Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus. Front Oncol 11:771545. https:\/\/doi.org\/10.3389\/fonc.2021.771545PubMedPMID:34993135;PubMedCentralPMCID:PMC8724023","journal-title":"Front Oncol"},{"issue":"9669","key":"2425_CR110","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","volume":"373","author":"BI Rini","year":"2009","unstructured":"Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet Lond Engl 373(9669):1119\u20131132. https:\/\/doi.org\/10.1016\/S0140-6736(09)60229-4. (PubMed PMID: 19269025)","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"2425_CR111","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12935-021-02039-yPubMedPMID:34193180;PubMedCentralPMCID:PMC8247248","volume":"21","author":"F Meng","year":"2021","unstructured":"Meng F, Zhang L, Zhang M, Ye K, Guo W, Liu Y et al (2021) Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma. Cancer Cell Int 21(1):332. https:\/\/doi.org\/10.1186\/s12935-021-02039-yPubMedPMID:34193180;PubMedCentralPMCID:PMC8247248","journal-title":"Cancer Cell Int"},{"key":"2425_CR112","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fcell.2020.00290PubMedPMID:32411707;PubMedCentralPMCID:PMC7198711","volume":"8","author":"C Zhao","year":"2020","unstructured":"Zhao C, Zhou Y, Ran Q, Yao Y, Zhang H, Ju J et al (2020) MicroRNA-381-3p Functions as a Dual Suppressor of Apoptosis and Necroptosis and Promotes Proliferation of Renal Cancer Cells. Front Cell Dev Biol 8:290. https:\/\/doi.org\/10.3389\/fcell.2020.00290PubMedPMID:32411707;PubMedCentralPMCID:PMC7198711","journal-title":"Front Cell Dev Biol"},{"key":"2425_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.697697PubMedPMID:35360452;PubMedCentralPMCID:PMC8962645","volume":"11","author":"L Chen","year":"2021","unstructured":"Chen L, Wang C, Wang Y, Hong T, Zhang G, Cui X (2021) Functions, Roles, and Biological Processes of Ferroptosis-Related Genes in Renal Cancer: A Pan-Renal Cancer Analysis. Front Oncol 11:697697. https:\/\/doi.org\/10.3389\/fonc.2021.697697PubMedPMID:35360452;PubMedCentralPMCID:PMC8962645","journal-title":"Front Oncol"},{"issue":"1","key":"2425_CR114","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12894-022-01037-0PubMedPMID:36104680;PubMedCentralPMCID:PMC9476343","volume":"22","author":"Z Wu","year":"2022","unstructured":"Wu Z, Huang X, Cai M, Huang P (2022) Potential biomarkers for predicting the overall survival outcome of kidney renal papillary cell carcinoma: an analysis of ferroptosis-related LNCRNAs. BMC Urol 22(1):152. https:\/\/doi.org\/10.1186\/s12894-022-01037-0PubMedPMID:36104680;PubMedCentralPMCID:PMC9476343","journal-title":"BMC Urol"},{"issue":"3","key":"2425_CR115","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s12094-024-03617-yPubMedPMID:39150660;PubMedCentralPMCID:PMC11914245","volume":"27","author":"YB Chen","year":"2025","unstructured":"Chen YB, Yang X, Lv D, Tang LY, Liu YW (2025) A prognostic model constructed by ferroptosis-associated genes (FAGs) in papillary renal cell carcinoma (PRCC) and its association with tumor mutation burden (TMB) and immune infiltration. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 27(3):1232\u20131247. https:\/\/doi.org\/10.1007\/s12094-024-03617-yPubMedPMID:39150660;PubMedCentralPMCID:PMC11914245","journal-title":"Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"key":"2425_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.851384PubMedPMID:35401700;PubMedCentralPMCID:PMC8984942","volume":"13","author":"J Hu","year":"2022","unstructured":"Hu J, Chen Y, Gao L, Ge C, Xie X, Lei P et al (2022) A Novel Pyroptosis-Related Gene Signature for Predicting Prognosis in Kidney Renal Papillary Cell Carcinoma. Front Genet 13:851384. https:\/\/doi.org\/10.3389\/fgene.2022.851384PubMedPMID:35401700;PubMedCentralPMCID:PMC8984942","journal-title":"Front Genet"},{"key":"2425_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.871602PubMedPMID:35402508;PubMedCentralPMCID:PMC8983933","volume":"9","author":"C Zhang","year":"2022","unstructured":"Zhang C, Huang R, Xi X (2022) Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Papillary Renal Cell Carcinoma. Front Mol Biosci 9:871602. https:\/\/doi.org\/10.3389\/fmolb.2022.871602PubMedPMID:35402508;PubMedCentralPMCID:PMC8983933","journal-title":"Front Mol Biosci"},{"key":"2425_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.741726PubMedPMID:35310430;PubMedCentralPMCID:PMC8930926","volume":"9","author":"X Tang","year":"2022","unstructured":"Tang X, Jiang F, Wang X, Xia Y, Mao Y, Chen Y (2022) Identification of the Ferroptosis-Related Long Non-Coding RNAs Signature to Improve the Prognosis Prediction in Papillary Renal Cell Carcinoma. Front Surg 9:741726. https:\/\/doi.org\/10.3389\/fsurg.2022.741726PubMedPMID:35310430;PubMedCentralPMCID:PMC8930926","journal-title":"Front Surg"},{"issue":"5","key":"2425_CR119","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2174\/0113862073303084240403051346","volume":"28","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Jin X, Liu J (2025) Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell Carcinoma. Comb Chem High Throughput Screen 28(5):883\u2013898. https:\/\/doi.org\/10.2174\/0113862073303084240403051346. (PubMed PMID: 38639274)","journal-title":"Comb Chem High Throughput Screen"},{"key":"2425_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.910928PubMedPMID:36275614;PubMedCentralPMCID:PMC9579370","volume":"9","author":"C Zhang","year":"2022","unstructured":"Zhang C, Huang R, Xi X (2022) Cuproptosis patterns in papillary renal cell carcinoma are characterized by distinct tumor microenvironment infiltration landscapes. Front Mol Biosci 9:910928. https:\/\/doi.org\/10.3389\/fmolb.2022.910928PubMedPMID:36275614;PubMedCentralPMCID:PMC9579370","journal-title":"Front Mol Biosci"},{"key":"2425_CR121","doi-asserted-by":"publisher","first-page":"1103986","DOI":"10.3389\/fphar.2022.1103986PubMedPMID:36618928;PubMedCentralPMCID:PMC9810632","volume":"13","author":"T Xie","year":"2022","unstructured":"Xie T, Liu B, Liu D, Zhou Y, Yang Q, Wang D et al (2022) Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma. Front Pharmacol 13:1103986. https:\/\/doi.org\/10.3389\/fphar.2022.1103986PubMedPMID:36618928;PubMedCentralPMCID:PMC9810632","journal-title":"Front Pharmacol"},{"issue":"8","key":"2425_CR122","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ccell.2023.07.006","volume":"41","author":"EP Henske","year":"2023","unstructured":"Henske EP, Cheng L, Hakimi AA, Choueiri TK, Braun DA (2023) Chromophobe renal cell carcinoma. Cancer Cell 41(8):1383\u20131388. https:\/\/doi.org\/10.1016\/j.ccell.2023.07.006. (PubMed PMID: 37541245)","journal-title":"Cancer Cell"},{"issue":"27","key":"2425_CR123","doi-asserted-by":"publisher","first-page":"E6274","DOI":"10.1073\/pnas.1710849115PubMedPMID:29891694;PubMedCentralPMCID:PMC6142242","volume":"115","author":"C Priolo","year":"2018","unstructured":"Priolo C, Khabibullin D, Reznik E, Filippakis H, Og\u00f3rek B, Kavanagh TR et al (2018) Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma. Proc Natl Acad Sci U S A 115(27):E6274\u2013E6282. https:\/\/doi.org\/10.1073\/pnas.1710849115PubMedPMID:29891694;PubMedCentralPMCID:PMC6142242","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"2425_CR124","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1038\/s41388-025-03562-2","volume":"44","author":"S Salem","year":"2025","unstructured":"Salem S, Han T, Alchoueiry M, Mahmoud N, Bzeih W, Chami J et al (2025) Targeting FSP1 to induce ferroptosis in chromophobe renal cell carcinoma. Oncogene 44(42):4075\u20134086. https:\/\/doi.org\/10.1038\/s41388-025-03562-2. (PubMed PMID: 40914768)","journal-title":"Oncogene"},{"issue":"1","key":"2425_CR125","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1186\/s12885-023-11589-5PubMedPMID:37940859;PubMedCentralPMCID:PMC10634106","volume":"23","author":"S Liu","year":"2023","unstructured":"Liu S, Yao Y, Hou M, Mei J, Sun L, Zhang G (2023) Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma. BMC Cancer 23(1):1079. https:\/\/doi.org\/10.1186\/s12885-023-11589-5PubMedPMID:37940859;PubMedCentralPMCID:PMC10634106","journal-title":"BMC Cancer"},{"key":"2425_CR126","doi-asserted-by":"publisher","unstructured":"Reznik E, Miller ML, \u015eenbabao\u011flu Y, Riaz N, Sarungbam J, Tickoo SK, et al. Mitochondrial DNA copy number variation across human cancers. eLife. 2016 Feb 22;5:e10769. https:\/\/doi.org\/10.7554\/eLife.10769 PubMed PMID: 26901439; PubMed Central PMCID: PMC4775221.","DOI":"10.7554\/eLife.10769"},{"issue":"3","key":"2425_CR127","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41588-019-0557-xPubMedPMID:32024997;PubMedCentralPMCID:PMC7058535","volume":"52","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ et al (2020) Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nat Genet 52(3):342\u2013352. https:\/\/doi.org\/10.1038\/s41588-019-0557-xPubMedPMID:32024997;PubMedCentralPMCID:PMC7058535","journal-title":"Nat Genet"},{"issue":"28","key":"2425_CR128","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2122840119PubMedPMID:35867762;PubMedCentralPMCID:PMC9651629","volume":"119","author":"L Zhang","year":"2022","unstructured":"Zhang L, Hobeika CS, Khabibullin D, Yu D, Filippakis H, Alchoueiry M et al (2022) Hypersensitivity to ferroptosis in chromophobe RCC is mediated by a glutathione metabolic dependency and cystine import via solute carrier family 7 member 11. Proc Natl Acad Sci U S A 119(28):e2122840119. https:\/\/doi.org\/10.1073\/pnas.2122840119PubMedPMID:35867762;PubMedCentralPMCID:PMC9651629","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2425_CR129","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.5858\/arpa.2017-0492-RS","volume":"143","author":"A Elliott","year":"2019","unstructured":"Elliott A, Bruner E (2019) Renal Medullary Carcinoma. Arch Pathol Lab Med 143(12):1556\u20131561. https:\/\/doi.org\/10.5858\/arpa.2017-0492-RS. (PubMed PMID: 30855171)","journal-title":"Arch Pathol Lab Med"},{"key":"2425_CR130","doi-asserted-by":"publisher","unstructured":"Vokshi BH, Davidson G, Tawanaie Pour Sedehi N, Helleux A, Rippinger M, Haller AR, et al. SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance. Nat Commun. 2023 May 26;14(1):3034. https:\/\/doi.org\/10.1038\/s41467-023-38472-y PubMed PMID: 37236926; PubMed Central PMCID: PMC10220073.","DOI":"10.1038\/s41467-023-38472-y"},{"issue":"6","key":"2425_CR131","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.immuni.2025.04.020PubMedPMID:40359940;PubMedCentralPMCID:PMC12186235","volume":"58","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Hu B, Deng Y, Soeung M, Bei L, Zhang Y et al (2025) Sickle cell disease induces chromatin introversion and ferroptosis in CD8+ T cells to suppress anti-tumor immunity. Immunity 58(6):1484-1501.e11. https:\/\/doi.org\/10.1016\/j.immuni.2025.04.020PubMedPMID:40359940;PubMedCentralPMCID:PMC12186235","journal-title":"Immunity"},{"key":"2425_CR132","doi-asserted-by":"publisher","unstructured":"Mj K, J M, Ja W, A O. Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction. Cancer Sci. 2018 Sep;109(9). https:\/\/doi.org\/10.1111\/cas.13701 PubMed PMID: 29917289.","DOI":"10.1111\/cas.13701"},{"issue":"5","key":"2425_CR133","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s44321-025-00221-7PubMedPMID:40148585;PubMedCentralPMCID:PMC12081665","volume":"17","author":"A Helleux","year":"2025","unstructured":"Helleux A, Davidson G, Lallement A, Hourani FA, Haller A, Michel I et al (2025) TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma. EMBO Mol Med 17(5):1041\u20131070. https:\/\/doi.org\/10.1038\/s44321-025-00221-7PubMedPMID:40148585;PubMedCentralPMCID:PMC12081665","journal-title":"EMBO Mol Med"},{"issue":"11","key":"2425_CR134","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tcb.2012.08.008PubMedPMID:22995729;PubMedCentralPMCID:PMC3568685","volume":"22","author":"DR Green","year":"2012","unstructured":"Green DR, Victor B (2012) The pantheon of the fallen: why are there so many forms of cell death? Trends Cell Biol 22(11):555\u2013556. https:\/\/doi.org\/10.1016\/j.tcb.2012.08.008PubMedPMID:22995729;PubMedCentralPMCID:PMC3568685","journal-title":"Trends Cell Biol"},{"issue":"4","key":"2425_CR135","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033PubMedPMID:22078876;PubMedCentralPMCID:PMC4511103","volume":"147","author":"Y Fuchs","year":"2011","unstructured":"Fuchs Y, Steller H (2011) Programmed cell death in animal development and disease. Cell 147(4):742\u2013758. https:\/\/doi.org\/10.1016\/j.cell.2011.10.033PubMedPMID:22078876;PubMedCentralPMCID:PMC4511103","journal-title":"Cell"},{"issue":"1","key":"2425_CR136","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1152\/physrev.00002.2021PubMedPMID:34898294;PubMedCentralPMCID:PMC8676434","volume":"102","author":"B Tummers","year":"2022","unstructured":"Tummers B, Green DR (2022) The evolution of regulated cell death pathways in animals and their evasion by pathogens. Physiol Rev 102(1):411\u2013454. https:\/\/doi.org\/10.1152\/physrev.00002.2021PubMedPMID:34898294;PubMedCentralPMCID:PMC8676434","journal-title":"Physiol Rev"},{"issue":"13","key":"2425_CR137","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1073\/pnas.1120680109PubMedPMID:22416118;PubMedCentralPMCID:PMC3324028","volume":"109","author":"CE Bender","year":"2012","unstructured":"Bender CE, Fitzgerald P, Tait SWG, Llambi F, McStay GP, Tupper DO et al (2012) Mitochondrial pathway of apoptosis is ancestral in metazoans. Proc Natl Acad Sci U S A 109(13):4904\u20134909. https:\/\/doi.org\/10.1073\/pnas.1120680109PubMedPMID:22416118;PubMedCentralPMCID:PMC3324028","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2425_CR138","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1158\/0008-5472.can-03-1541","volume":"64","author":"KV Gurova","year":"2004","unstructured":"Gurova KV, Hill JE, Razorenova OV, Chumakov PM, Gudkov AV (2004) p53 pathway in renal cell carcinoma is repressed by a dominant mechanism. Cancer Res 64(6):1951\u20131958. https:\/\/doi.org\/10.1158\/0008-5472.can-03-1541. (PubMed PMID: 15026329)","journal-title":"Cancer Res"},{"issue":"9","key":"2425_CR139","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/procel\/pwae003PubMedPMID:38428031;PubMedCentralPMCID:PMC11365558","volume":"15","author":"C Mao","year":"2024","unstructured":"Mao C, Wang M, Zhuang L, Gan B (2024) Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond. Protein Cell 15(9):642\u2013660. https:\/\/doi.org\/10.1093\/procel\/pwae003PubMedPMID:38428031;PubMedCentralPMCID:PMC11365558","journal-title":"Protein Cell"},{"issue":"4","key":"2425_CR140","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.devcel.2020.06.019PubMedPMID:32652074;PubMedCentralPMCID:PMC7483868","volume":"54","author":"MA Perez","year":"2020","unstructured":"Perez MA, Magtanong L, Dixon SJ, Watts JL (2020) Dietary Lipids Induce Ferroptosis in Caenorhabditiselegans and Human Cancer Cells. Dev Cell 54(4):447-454.e4. https:\/\/doi.org\/10.1016\/j.devcel.2020.06.019PubMedPMID:32652074;PubMedCentralPMCID:PMC7483868","journal-title":"Dev Cell"},{"issue":"14","key":"2425_CR141","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003PubMedPMID:35803244;PubMedCentralPMCID:PMC9273022","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR (2022) Ferroptosis turns 10: Emerging Mechanisms, Physiological Functions, and Therapeutic Applications. Cell 185(14):2401\u20132421. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003PubMedPMID:35803244;PubMedCentralPMCID:PMC9273022","journal-title":"Cell"},{"issue":"4","key":"2425_CR142","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/cdd.2011.1PubMedPMID:21293492;PubMedCentralPMCID:PMC3131909","volume":"18","author":"Q Remijsen","year":"2011","unstructured":"Remijsen Q, Kuijpers TW, Wirawan E, Lippens S, Vandenabeele P, Vanden BT (2011) Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ 18(4):581\u2013588. https:\/\/doi.org\/10.1038\/cdd.2011.1PubMedPMID:21293492;PubMedCentralPMCID:PMC3131909","journal-title":"Cell Death Differ"},{"issue":"5","key":"2425_CR143","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.cell.2007.10.040","volume":"131","author":"M Overholtzer","year":"2007","unstructured":"Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW et al (2007) A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131(5):966\u2013979. https:\/\/doi.org\/10.1016\/j.cell.2007.10.040. (PubMed PMID: 18045538)","journal-title":"Cell"},{"issue":"6","key":"2425_CR144","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s41556-025-01673-2","volume":"27","author":"J Wan","year":"2025","unstructured":"Wan J, Shi JH, Shi M, Huang H, Zhang Z, Li W et al (2025) Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8+ T cells. Nat Cell Biol 27(6):972\u2013982. https:\/\/doi.org\/10.1038\/s41556-025-01673-2. (PubMed PMID: 40461882)","journal-title":"Nat Cell Biol"},{"issue":"18","key":"2425_CR145","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/eurheartj\/ehae205PubMedPMID:38666340;PubMedCentralPMCID:PMC11089336","volume":"45","author":"K Yang","year":"2024","unstructured":"Yang K, Gao R, Chen H, Hu J, Zhang P, Wei X et al (2024) Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition. Eur Heart J 45(18):1662\u20131680. https:\/\/doi.org\/10.1093\/eurheartj\/ehae205PubMedPMID:38666340;PubMedCentralPMCID:PMC11089336","journal-title":"Eur Heart J"},{"issue":"459","key":"2425_CR146","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cca.2016.05.029","volume":"1","author":"S Masuda","year":"2016","unstructured":"Masuda S, Nakazawa D, Shida H, Miyoshi A, Kusunoki Y, Tomaru U et al (2016) NETosis markers: Quest for specific, objective, and quantitative markers. Clin Chim Acta Int J Clin Chem 1(459):89\u201393. https:\/\/doi.org\/10.1016\/j.cca.2016.05.029. (PubMed PMID: 27259468)","journal-title":"Clin Chim Acta Int J Clin Chem"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02425-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02425-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02425-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:48:50Z","timestamp":1791744530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02425-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":146,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2425"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02425-9","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"239"}}